Original Article By: Transparency Market Research
Summarized By: Neurobit
The global BiPAP (bi-level positive airway pressure) devices market is growing due to increased adoption for the treatment of respiratory problems and sleep disorders. The market size was valued at $299.7 million in 2021 and is expected to reach $511.6 million by 2031. The rise in adoption of advanced BiPAP devices, such as auto-adjusting BiPAP, is a key factor driving market growth. BiPAP machines are frequently used to treat chronic obstructive pulmonary disease (COPD) and are popular among patients due to their lightweight, portable, and effective nature.
Key drivers of the market include the rise in public awareness about sleep disorders and the increasing demand for PAP therapies to treat sleep apnea and related breathing disorders. The sleep apnea segment holds a dominant share in the BiPAP devices market. Increased R&D activities by prominent companies in the North America region have fueled market growth, with the region holding a significant share in the market. The Asia Pacific region is expected to experience the highest growth rate, driven by the demand for PAP therapies for sleep disorders and the large patient population in the region.
The BiPAP devices market is fragmented with many players, leading companies are focusing on expanding their product portfolio and pursuing mergers and acquisitions to strengthen their position in the market. Partnerships and collaborations are also common strategies among players to increase market share.
Transparency Market Research. (2023, January 26). BiPAP Devices Market to Exceed US$ 511.6 Million at a CAGR of 5.5% by 2031: Transparency Market Research, Inc. Yahoo. Retrieved January 31, 2023, from https://www.yahoo.com/now/bipap-devices-market-exceed-us-213000081.html